Results 101 to 110 of about 7,551 (201)
Updates in the treatment of chronic hepatitis B [PDF]
, 2008 published_or_final_versio
Fung, J, Lai, CL, Yuen, MF
core
Telbivudine versus lamivudine in patients with chronic hepatitis B [PDF]
, 2007 BACKGROUND: Reducing hepatitis B virus (HBV) replication to minimal levels is emerging as a key therapeutic goal for chronic hepatitis B. METHODS: In this double-blind, phase 3 trial, 1370 patients with chronic hepatitis B were randomly assigned to ...
Adrian M. Di Bisceglie +19 more
core +1 more source
The association between maternal hepatitis B e antigen status, as a proxy for perinatal transmission, and the risk of hepatitis B e antigenaemia in Gambian children. [PDF]
, 2014 BACKGROUND: Early age at infection with hepatitis B virus (HBV) increases the risk of chronic HBV infection. In addition early age at infection may further increase the risk of persistent viral replication beyond its effect on chronicity.
Bottomley, Christian +3 more
core +4 more sources
Insights into the Natural and Treatment Courses of Hepatitis B in Children: A Retrospective Study
BiomedicinesChronic Hepatitis B virus (HBV) infection in children remains a significant public health challenge. The natural history and treatment outcomes of HBV can vary widely, influencing management strategies. This retrospective study was conducted in Northeast
Lorenza Forna +9 more
doaj +1 more source
Reactivation of Hepatitis B Infection During the Cause of Non Hodgkin\u27s Lymphoma Chemotherapy [PDF]
, 2014 Hepatitis due to hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy is a serious cause of liver-related morbidity and mortality.
H, D. J. (Diana), Mustika, S. (Syifa)
core +1 more source
Chinese Medical Journal, 2018 Background: Until now, various types of combined therapy with nucleotide analogs and pegylated interferon (Peg-INF) in patients with hepatitis B patients have been tried.
Dae Won Jun +21 more
doaj +1 more source
Progress in hepatitis B: A 30‐year journey through three continents [PDF]
, 2014 Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/107540/1/hep27120 ...
Lok, Anna Suk‐fong
core +1 more source
The natural history of chronic hepatitis B infection [PDF]
, 1997 Chronic hepatitis B infection is a global health problem that affects about 300 million people. Of these, 75% are Chinese. Most Chinese who become chronic carriers, contract the virus during the perinatal period.
Lai, CL, Lau, GKK, Wu, PC
core
Infection International, 2014 Abstract Objective To investigate the efficiency of pegylated interferon α therapy for patients with HBeAg-positive chronic hepatitis B (CHB) and explore whether liver histopathological features and other factors might influence HBeAg seroconversion.
Yao-ren Hu +4 more
openaire +1 more source
Serum levels of preS antigen (HBpreSAg) in chronic hepatitis B virus infected patients
Virology Journal, 2007 Background Hepatitis B virus (HBV) infection is a serious health problem worldwide. Treatment recommendation and response are mainly indicated by viral load, e antigen (HBeAg) seroconversion, and ALT levels.
Gu Xiaocheng +8 more
doaj +1 more source